Armenia Medical Device Compliance: EAEU Unified Safety Database under Order No. 177

1. Key takeaways

The Union has established a unified information database for monitoring the safety, quality and effectiveness of medical devices; its general process is implemented by Board Order No. 177 of the Eurasian Economic Commission dated 2018-11-12, and the accession procedure for new participants is approved by Board Decision No. 94 dated 2016-08-30. The GRZAN conclusion: the database turns the surveillance obligations of Decision No. 174 into a data flow — the output side of a post-market system no longer consists of submissions to a single member state but enters a Union-level unified information flow. For registration certificates covering several countries at the same time, this point is especially critical, because one data set may need to serve multiple jurisdictions simultaneously.

2. Legal basis

3. Expert insights

Insight 1: Order No. 177 establishes a general process, not a new obligation. The order provides that, from the date of its entry into force, the general process for the formation, maintenance and use of the unified information database for monitoring the safety, quality and effectiveness of medical devices is implemented. GRZAN note: this is an information infrastructure arrangement; the substantive obligations still come from Decision No. 174. Companies should not read it as adding new reporting duties — rather, the carrier and route of reporting are unified.

Insight 2: Accession follows a country-by-country mechanism. The order provides that the accession of new participants to the general process it implements must follow the procedure for accession to the general process for the formation, maintenance and use of the unified information database, approved by Board Decision No. 94 of 2016-08-30. GRZAN note: this means member states are connected in batches; the set of member states covered by the database at any point in time is not fixed, and submission routes must be adjusted as accession progresses (practical estimate: Armenia’s accession status and the specific submission entry point should be confirmed against what the competent authority publishes).

Insight 3: The entry-into-force mechanism is unified as 10 calendar days after publication. The order provides that it enters into force 10 calendar days after its publication on the official website of the Eurasian Economic Union. GRZAN note: together with the 10 calendar days after the entry into force of a protocol used for Council decisions, the 30 calendar days used for Board decisions, and the 180 calendar days of Decision No. 144, this forms four types of entry-into-force clauses covered by this topic; each should be identified individually during verification.

Insight 4: The database corresponds to the three data sources of Decision No. 174. The three surveillance bases established by Article 4 of Decision No. 174 (adverse event reports, periodic reports, and the manufacturer’s post-market data system with corrective actions) ultimately converge into the unified information flow. GRZAN note: when building a post-market system, data fields should be organized according to the database’s field requirements, so as to avoid later conversion costs.

Insight 5: Interface with the national surveillance function. Article 45 of the Law on Medical Care and Services for the Population provides that the powers of the authorized body include ensuring the collection and analysis of information on adverse events (incidents) and the adoption of the relevant decisions. GRZAN note: the Armenian competent authority performs the collection and analysis function; submissions made in Armenia should simultaneously satisfy national law and the Union information flow requirements, and the authorized representative should clarify its submission duties and record-keeping method.

4. Practical recommendations

1. Organize data by database fields: design the data fields of the post-market system according to the unified information database to reduce later conversion work.
2. Track accession progress: periodically review each member state’s database accession status and update submission routes (practical estimate).
3. Keep submission records: retain the sending record, reception confirmation and timestamp of every submission as compliance evidence.
4. Put authorized representative duties into the contract: state in the authorization letter the duties, deadlines and record-keeping requirements for post-market information submission.
5. Distinguish obligation from carrier: explain to management that the database is a carrier while the obligations still come from Decision No. 174, to avoid misjudging the compliance scope.

5. Verification checklist

1. □ Confirmed that the general process of the unified information database is implemented by Board Order No. 177 of 2018-11-12.
2. □ Confirmed that accession of new participants follows Board Decision No. 94 of 2016-08-30.
3. □ Confirmed that the order enters into force 10 calendar days after publication on the Union’s official website.
4. □ Designed post-market data fields according to the database standard.
5. □ Established a record-keeping mechanism covering the sending record, reception confirmation and timestamp of every submission.
6. □ Stated in the authorization letter the duties and deadlines for post-market information submission.
7. □ Periodically reviewed member state accession status and updated submission routes (practical estimate noted).

Regulatory information verified as of October 30, 2026.

About GRZAN: GRZAN supports medical device manufacturers entering Armenia and the Eurasian Economic Union with regulatory registration, quality management systems, post-market surveillance and import clearance compliance. For inquiries, contact info@grzanglobal.com.